# Hypoxia-altitude Testing to Predict Altitude Related Adverse Health Effects in Chronic Obstructive Pulmonary Disease (COPD) Patients

> **NCT04915378** · — · COMPLETED · sponsor: **University of Zurich** · enrollment: 75 (actual)

## Conditions studied

- Hypoxia Altitude Simulation Test
- High Altitude

## Interventions

- **OTHER:** hypoxia altitude simulation test (HAST) at 760m
- **PROCEDURE:** High Altitude (3100m)

## Key facts

- **NCT ID:** NCT04915378
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2021-09-01
- **Final completion:** 2022-05-31
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2022-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04915378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04915378, "Hypoxia-altitude Testing to Predict Altitude Related Adverse Health Effects in Chronic Obstructive Pulmonary Disease (COPD) Patients". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04915378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*